Back to top

JonesTrading Sticks to Their Hold Rating for Editas Medicine (EDIT)

In a report released today, Soumit Roy from JonesTrading reiterated a Hold rating on Editas Medicine (EDIT – Research Report). The company’s shares...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Editas Medicine, Inc. (EDIT)